Safe Handling of Hazardous Oral Drugs: A Primer for Pharmacy Technicians
A Pharmacy Technician Digital Article
This activity is supported by
MJH Life Sciences™, the parent company of Pharmacy Times® and PTCE.
MJH Life Sciences™, the parent company of Pharmacy Times® and PTCE.
Faculty
Soniya Chandrasekhara, PharmD, BCOP
Clinical Pharmacy Coordinator – Hematology/Oncology
NewYork-Presbyterian Brooklyn Methodist Hospital
Brooklyn, New York
Target audience: Pharmacy technicians
Type of activity: Knowledge
Release date: December 14, 2020
Expiration date: December 14, 2021
Estimated time to complete activity: 1.0 hour
Fee: Free
Activity Overview
Pharmacy technicians and other health care workers who handle, compound, dispose of, or clean equipment used with hazardous drugs are at risk for adverse effects. Oral therapeutic options have become available alongside intravenous infusions and contain similar risk of adverse effects if incorrectly handled by a health care worker. As pharmacy technicians are involved in many aspects of drug preparation and medication delivery, knowledge of the classes of hazardous drugs, available guidelines, and documented safety practices for handling hazardous oral medications is critical to maintain their health and promote safe practices within their workplace. Requirements for safe storage, disposal, and other steps in the delivery of hazardous drugs from leading organizations are discussed.
Educational Objectives
At the completion of this activity, the participant will be able to:
- List types of exposure and potential hazards from accidental exposure
- Recognize classes of drugs with examples that require safe handling
- Review specific processes including storage, preparation, dispensing, and waste of hazardous drugs to reduce exposure and risk
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-20-350-H05-T. The activity is available for CE credit through December 14, 2021.Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, read the article, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Soniya Chandrasekhara, PharmD, BCOP
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Ann Marciano; Susan Pordon; and Brianna Winters
Pharmacy Times® Editorial Staff—Davy James
An anonymous peer reviewer was part of the content validation and conflict resolution and has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
